Correlation Between Inhibrx Biosciences, and Celtic Plc

Can any of the company-specific risk be diversified away by investing in both Inhibrx Biosciences, and Celtic Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx Biosciences, and Celtic Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx Biosciences, and Celtic plc, you can compare the effects of market volatilities on Inhibrx Biosciences, and Celtic Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx Biosciences, with a short position of Celtic Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx Biosciences, and Celtic Plc.

Diversification Opportunities for Inhibrx Biosciences, and Celtic Plc

0.82

Correlation Coefficient

Inhibrx Biosciences,  Celtic Plc

Very poor diversification

The 3 months correlation between Inhibrx and Celtic is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx Biosciences, and Celtic plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celtic plc and Inhibrx Biosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx Biosciences, are associated (or correlated) with Celtic Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celtic plc has no effect on the direction of Inhibrx Biosciences, i.e., Inhibrx Biosciences, and Celtic Plc go up and down completely randomly.

Pair Corralation between Inhibrx Biosciences, and Celtic Plc

Given the investment horizon of 90 days Inhibrx Biosciences, is expected to generate 0.82 times more return on investment than Celtic Plc. However, Inhibrx Biosciences, is 1.22 times less risky than Celtic Plc. It trades about 0.31 of its potential returns per unit of risk. Celtic plc is currently generating about 0.16 per unit of risk. If you would invest  1,300  in Inhibrx Biosciences, on May 5, 2025 and sell it today you would earn a total of  860.00  from holding Inhibrx Biosciences, or generate 66.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Inhibrx Biosciences,  vs.  Celtic plc

Inhibrx Biosciences,

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx Biosciences, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental drivers, Inhibrx Biosciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Celtic plc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Celtic plc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Celtic Plc reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Inhibrx Biosciences, and Celtic Plc

The main advantage of trading using opposite Inhibrx Biosciences, and Celtic Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx Biosciences, position performs unexpectedly, Celtic Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celtic Plc will offset losses from the drop in Celtic Plc's long position.

The idea behind Inhibrx Biosciences, and Celtic plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.